ELV News

(NYSE:ELV) OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has assigned a Long-Term Issue Credit Rating of “bbb+” (Good) to Elevance Health Inc.’s (Elevance Health) (headquartered in Indianapolis, IN) newly issued senior unsecured notes of $750 million, 4.0% senior unsecured notes, due 2028; $750 million, 4.6% senior unsecured notes, due 2032; $1 billion, 5.0% senior unsecured notes, due 2036; and $500 million, 5.7% senior unsecured notes, due 2055. The outlook assigned to this Credit Rating is stable. The procee

(NYSE:ELV) INDIANAPOLIS--(BUSINESS WIRE)--The Elevance Health Foundation has awarded 29 new grants totaling more than $6.5 million to support maternal and infant health programs across the country. The funding will drive innovative, scalable solutions spanning pre-conception care, pregnancy, delivery, postpartum, and infant health, with a focus on reducing disparities and improving outcomes. This latest round of funding is part of the Foundation’s five-year, $150 million commitment to addressing the physi

INDIANAPOLIS--(BUSINESS WIRE)-- #ElevanceHealth--Elevance Health and the National Association of Community Health Centers (NACHC) are proud to announce the integration of Food as Medicine (FAM) programming with primary care Community Health Centers (CHCs). This milestone - built on a shared commitment to whole health and community-centered innovation - marks a transformative step forward in addressing food/nutrition insecurity and diet-related chronic conditions through clinical integration. A Whole Health Appro

WOODLAND HILLS, Calif.--(BUSINESS WIRE)--Anthem Blue Cross is pleased to announce its Commercial and Covered California (Exchange) health plans in California have been awarded full Health Equity Accreditation by the National Committee for Quality Assurance (NCQA) through July 28, 2028. This nationally recognized accreditation is granted to organizations demonstrating leadership in closing health outcome gaps and providing culturally and linguistically appropriate services that promote equitable

COLUMBUS, Ohio--(BUSINESS WIRE)--Anthem Blue Cross and Blue Shield (Anthem), a leading provider of health benefits for Ohio residents enrolled in the state’s Medicaid managed care program, announced today that Michelle Stoughton has been named president of its Medicaid health plan. “Michelle is a highly respected leader with extensive experience in healthcare policy and government,” said Jennie Reynolds, east region president of Anthem Medicaid. “Her proven track record in Ohio and her dedicati

NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE: ELV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Elevance Health, Inc. (“Elevance” or “the Company”) (NYSE: ELV) and certain of its officers.

NEW YORK, June 17, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the Class Period), of the important July 11, 2025...

LOS ANGELES, June 17, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming July 11, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE: ELV) common stock between April 18, 2024, and October 16, 2024, inclusive (the “Class Period”).

NEW YORK, June 17, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Elevance Health, Inc. (Elevance or the Company) (NYSE: ELV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or...

NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the “Class Period”), of the important July 11, 2025 lead plaintiff deadline.

Elevance Health, Inc. investors that lost money are notified to contact BFA Law before July 11, 2025 securities fraud class action deadline.

The lawsuit alleges that from 2016 through at least 2021, the insurers paid hundreds of millions of dollars in illegal kickbacks to brokers.

Robert F. Kennedy Jr. has taken office as HHS secretary, which could impact the healthcare sector, including ETFs with exposure to insurers like UnitedHealth and Elevance Health.

The U.S. Senate voted on Thursday to confirm President Donald Trump's nomination of Robert F. Kennedy Jr. to lead the Department of Health and Human Services.

Humana reported a Q4 adjusted EPS loss of $2.16 while revenue grew 13.5% year-over-year to $29.19 billion.

President-elect Donald Trump on Tuesday said that he will nominate celebrity physician Dr. Mehmet Oz to lead the Centers for Medicare & Medicaid Services (CMS).